Please try another search
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company’s product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Sol J. Barer | 74 | 2019 | Independent Chairman of the Board |
Kristi Jones | 59 | 2017 | CEO, President & Director |
Paul D’Angio | 63 | 2017 | Independent Director |
Grant L. Verstandig | 32 | 2021 | Independent Director |
Paul Richardson | - | - | Member of Scientific Advisory Board |
Andreas Mackensen | - | 2021 | Member of Scientific Advisory Board |
Miguel-Angel Perales | - | 2021 | Member of Scientific Advisory Board |
Yi Lin | - | 2021 | Member of Scientific Advisory Board |
Kevan Herold | - | 2021 | Member of Scientific Advisory Board and Autoimmune & Infectious Disease Scientific Advisory Board |
Michelle Krogsgaard | - | 2021 | Member of Scientific Advisory Board |
David A. Hafler | - | 2022 | Member of Autoimmune & Infectious Disease Scientific Advisory Board |
Zhengbin Yao | 56 | 2017 | Independent Director |
Robert Siliciano | - | 2022 | Member of Autoimmune & Infectious Disease Scientific Advisory Board |
Marcela V. Maus | 45 | 2021 | Member of Scientific Advisory Board |
Robin A. Robinson | 65 | 2022 | Member of Autoimmune & Infectious Disease Scientific Advisory Board |
David Samuel diCapua Siegel | - | 2021 | Member of Scientific Advisory Board |
James G. Krueger | - | 2022 | Member of Autoimmune & Infectious Disease Scientific Advisory Board |
Juan Varela | - | 2021 | Member of Scientific Advisory Board |
Anil K. Rustgi | - | 2021 | Member of Scientific Advisory Board |
Gerald T. Nepom | - | 2022 | Chair of Autoimmune & Infectious Disease Scientific Advisory Board |
Timothy A. Bertram | 68 | 2017 | Independent Director |
Alan S. Roemer | 53 | 2017 | Independent Director |
Jonathan Schneck | - | 2012 | Co-Chairman of Scientific Advisory Board |
Jeffrey S. Weber | - | 2021 | Chief Scientific Advisor, Co-Chairman of Scientific Advisory Board and Member of AI & ID SAB |
Leena Gandhi | 52 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review